mTORC1 regulates a lysosome-dependent adaptive shift in intracellular lipid speciesAaron M. Hosios, Brendan D. Manning, Krystle C. Kalafut et al.|Nature Metabolism|2022Cited by 53
IMPDH inhibitors for antitumor therapy in tuberous sclerosis complexAlexander J. Valvezan, Brendan D. Manning, Molly C. McNamara et al.|JCI Insight|2020Cited by 38
Reciprocal effects of mTOR inhibitors on pro-survival proteins dictate therapeutic responses in tuberous sclerosis complexMolly C. McNamara, Brendan D. Manning, Aaron M. Hosios et al.|iScience|2022Cited by 5
IMPDH inhibitors for anti-tumor therapy in tuberous sclerosis complexAlexander J. Valvezan, Brendan D. Manning, Elizabeth P. Henske et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 4